Among the chromatin-modifier mutations observed in bladder cancer, a few of them are especially high, including KMT2D (28%), KDM6A (26%), and ARID1A (25%), which are observed in muscle-invasive bladder cancer [2]. Here, KDM6A is linked to urinary bladder cancer.